CAS 1226549-49-0

DBPR112

CAS : 1226549-49-0

DBPR112

Degré de pureté : ≥98%

Masse moléculaire : 533.62g/mol

Ref: 54-BUP14272

DBPR112

CAS : 1226549-49-0

DBPR112 is an analog that belongs to the group of kinase inhibitors. It has been shown to inhibit various kinases, which are enzymes involved in cellular signaling pathways that regulate cell growth and division. DBPR112 has demonstrated anticancer activity in vitro against a range of cancer cells, including Chinese hamster ovary cells, human breast cancer cells, and tumor xenografts. It also induces apoptosis, or programmed cell death, in cancer cells. DBPR112 is excreted in urine and may be used as a potential biomarker for monitoring anticancer therapy. This drug is not related to oseltamivir or any other antiviral medication but rather acts on protein targets within the cancer cell.

Formule : C₃₂H₃₁N₅O₃

Degré de pureté : Min. 95%

Masse moléculaire : 533.6 g/mol

Ref: 3D-BZB54949

DBPR112

CAS : 1226549-49-0

DBPR112: oral furanopyrimidine EGFR inhibitor; IC50: 15 nM (EGFRWT), 48 nM (L858R/T790M); blocks ATP site, strong antitumor effects.

Formule : C₃₂H₃₁N₅O₃

Degré de pureté : 99.25%

Couleur et forme : Solid

Masse moléculaire : 533.62

Ref: TM-T10965